Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
Anticancer drugs in monotherapy are ineffective to treat various kinds of cancer due to the heterogeneous nature of cancer. Moreover, available anticancer drugs possessed various hurdles, such as drug resistance, insensitivity of cancer cells to drugs, adverse effects and patient inconveniences. Hen...
Main Authors: | Girish Kumar, Tarun Virmani, Ashwani Sharma, Kamla Pathak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/889 |
Similar Items
-
Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
by: Yu-Ling Yang, et al.
Published: (2021-11-01) -
Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy
by: Ting Su, et al.
Published: (2023-08-01) -
Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance
by: Jianing Gong, et al.
Published: (2023-05-01) -
Lead phytochemicals for anticancer drug development
by: Sukhdev Singh, et al.
Published: (2016-11-01) -
A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer
by: Yufan Guo, et al.
Published: (2022-02-01)